Clinical Trial Detail

NCT ID NCT03899155
Title Pan Tumor Nivolumab Rollover Study
Recruitment Recruiting
Gender both
Phase FDA approved
Variant Requirements No
Sponsors Bristol-Myers Squibb
Indications

cancer

Therapies

Nivolumab

Age Groups: adult senior

No variant requirements are available.